ESG Inc. financial data

Symbol
PMIN on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
523 School House Rd, Kennett Square, Pennsylvania
State of incorporation
Nevada
Fiscal year end
December 31
Former names
PLASMA INNOVATIVE INC. (to 11/13/2023)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 18.6 %
Debt-to-equity 139 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.9 M shares +67.5%
Common Stock, Shares, Outstanding 25.9 M shares +67.5%
Entity Public Float 0 USD
Common Stock, Value, Issued 25.9 K USD +67.5%
Weighted Average Number of Shares Outstanding, Basic 25.9 M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 25.9 M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.38 M USD +31.5%
Cost of Revenue 2.47 M USD +68.5%
Research and Development Expense 131 K USD +0.68%
General and Administrative Expense 318 K USD +16.5%
Operating Income (Loss) -540 K USD -791%
Nonoperating Income (Expense) -245 K USD -101%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -785 K USD -331%
Net Income (Loss) Attributable to Parent -588 K USD -313%
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted -0.03 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 833 K USD +5706%
Inventory, Net 718 K USD
Assets, Current 2.15 M USD +2790%
Property, Plant and Equipment, Net 769 USD -25.3%
Assets 25.3 M USD +33573%
Accounts Payable, Current 1.3 M USD +130160%
Liabilities, Current 1 K USD -70.3%
Liabilities 1 K USD -70.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -590 K USD
Retained Earnings (Accumulated Deficit) -1.81 M USD -2650%
Stockholders' Equity Attributable to Parent 8.78 M USD +11720%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.8 M USD -12.2%
Liabilities and Equity 25.3 M USD +33573%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 95 K USD -80.9%
Net Cash Provided by (Used in) Financing Activities 138 K USD
Common Stock, Shares Authorized 65 M shares 0%
Common Stock, Shares, Issued 25.9 M shares +67.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 491 K USD +37.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 833 K USD +47.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 150 K USD +5.58%
Deferred Tax Assets, Valuation Allowance 2.7 M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Depreciation 65 USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -747 K USD -653%
Property, Plant and Equipment, Gross 24.5 M USD
Deferred Income Tax Expense (Benefit) -174 K USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 2.7 M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Additional Paid in Capital 11.2 M USD +8843%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 17 K USD -2.56%
Depreciation, Depletion and Amortization 453 K USD -3.87%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%